Statistics from Altmetric.com
Commentary on: Lennox B, Palmer-Cooper E, Pollak T, et al. Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case–control study. Lancet Psychiatry 2017;4:42–8.
What is already known on this topic?
Antineuronal antibody-mediated encephalitis frequently presents with prominent psychiatric features. It has been hypothesised that antineuronal antibodies may play a pathophysiological role in subgroups of patients with psychotic disorders. Whereas a few large studies find a similar prevalence of antineuronal antibodies in patients with psychotic disorders, other psychiatric disorders and healthy controls,1 2 there is some evidence of an increased prevalence of N-methyl-D-aspartate receptor (NMDAR) antibodies in patients with first-episode psychosis.3 4 In their present study, the authors aimed to (1) investigate the prevalence of neuronal cell surface antibodies in patients with first-episode psychosis and healthy controls and (2) compare the clinical and cognitive profile of patient’s with and without these antibodies.
Methods of the study
The subjects in this observational study …
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.